Cochrane · intervention · CD012416

Oral care measures for preventing nursing home‐acquired pneumonia

Cao, Y, Liu, C, Lin, J, et al. · Cochrane Database of Systematic Reviews · 2022 · Cochrane Library

Oral HealthDental public health and special care3 versionsAMSTAR 2: not assessed
Full textEvery question was extracted from the full review (methods and results), not only its Summary of Findings table.
Questions
9
current version
GRADE rated
3
No studies
2
Included studies
6
as reported
No studies 2 · 22.2%Ungraded 4 · 44.4%Very low 1 · 11.1%Low 2 · 22.2%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Review question

ElementPlanned (methods)Found (results)
PopulationResidents of any age in nursing homes and other long‐term care facilities (e.g. rehabilitation units, medical care facilities), regardless of oral health status (e.g. edentulous or dentate, with or without dentures, with or without physical or intellectual disabilities, with or without mechanical ventilation, with or without alternative feeding route). We excluded participants with pneumonia or respiratory infection at baseline.6244 randomised participants (not including 14 participants excluded as not meeting eligibility criteria after cluster randomisation). 5976 participants available for analysis after exclusions. Mean age ranged from 79 to 88 years in four studies that reported demographics, and the proportion of males ranged from 21% to 40%.
InterventionOral care measures versus no treatment, placebo, usual care, or any other oral care measure (head‐to‐head trials) for prevention of NHAP. Intervention group: participants receiving one or more clearly defined oral care measures, such as professional oral care (dentists, dental hygienists, nurse‐assisted tooth brushing), oral rinse, or swab and topical decontamination with antiseptics, regardless of frequency, dosage, or formulation.Professional oral care (n=6)
ComparisonPlacebo/No treatment/Usual care (including self‐care)/Any other oral care measure (or combination or oral care measures)Usual oral care (n=6)
OutcomesIncidence, incidence proportion, or prevalence of NHAP of any severity; Mortality (pneumonia‐associated); Mortality (all‐cause); Change in systemic antibiotic use; Adverse reactions to interventions (both local and systemic); Incidence or prevalence of fever; Change in data on economics (costs or cost‐effectiveness) and quality of life; Oral health indicesIncidence rate of NHAP (n=1); Incidence proportion of NHAP (n=1); Hazard ratio for NHAP (n=3); Mortality pneumonia‐associated (n=3); Mortality all‐cause (n=3); Adverse reactions to interventions (n=1); Incidence or prevalence of fever (n=2); Change in data on economics and quality of life (n=1); Oral health indices (n=2)
Study designsParallel randomised controlled trials (RCTs) assessing the effects of oral care measures in residents of nursing and other long‐term care facilities. We included cluster‐RCTs, for which the unit of randomisation was the care facility. We excluded cross‐over studies.NR
TimingNot specified8‐month follow‐up (n=1); 18‐month follow‐up (n=1); 24‐month follow‐up (n=3); Variable follow‐up with mean 1.13 years (n=1)

Search date: 12 May 2022. Databases: Cochrane Oral Health's Trials Register; Cochrane Central Register of Controlled Trials (CENTRAL); MEDLINE Ovid; Embase Ovid; CINAHL EBSCO; US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov; World Health Organization International Clinical Trials Registry Platform

Questions and results

Current version only

Professional oral care vs Usual oral care

Population: Residents of nursing homes and other long-term care facilities
CD012416.PUB3 (current) · 8 questions
OutcomeEffectEvidenceStatus / GRADE
Mortality (all-cause)
12-30 months
All-cause mortality, follow-up 12-30 months, 3764 (3 studies), Very low. Not pooled. Adachi RR 0.80 (0.40 to 1.58; 88); Juthani-Mehta HR 1.16 (0.88 to 1.53; 834); Zimmerman adjusted IRR 0.83 (0.61 to 1.12; 1606).…3 studies · 3764 participantsVery low
Downgraded: risk of bias, imprecision
Adverse effects of interventions
Measured in only 1 study (834 participants), which reported no serious events and 64 non-serious events, the most common of which were oral cavity disturbances (not defined) and dental staining.1 study · 834 participantsUngraded
Mortality (pneumonia-associated)
24 months
RR 0.43 [0.25, 0.76]
165 per 1000 vs 71 per 1000
2 studies · 454 participantsLow
Downgraded: risk of bias, inconsistency
Incidence of NHAP
8-30 months
Incidence of NHAP, follow-up 8-30 months, 5018 (5 studies), Low. Not pooled (individual and cluster-randomised designs, varying effect measures and follow-up). Component estimates: Bourigault HR 0.65 (0.29 to 1.46;…5 studies · 5018 participantsLow
Downgraded: risk of bias, imprecision
Incidence or prevalence of fever
24 months
RR 0.49 [0.33, 0.75]1 study · 366 participantsUngraded
Change in data on economics and quality of life
24 months
MD 1.5 [0.32, 2.68]1 study · 322 participantsUngraded
Oral health indices
24 months
RR 2.81 [1.39, 5.69]1 study · 199 participantsUngraded
Change in systemic antibiotic use
No studies measured change in systemic antibiotic use.0 studiesNo studies

Oral care vs No oral care

Population: Residents of nursing homes and other long-term care facilities
CD012416.PUB3 (current) · 1 question
OutcomeEffectEvidenceStatus / GRADE
Outcome NR
No studies evaluated oral care versus no oral care.0 studiesNo studies

Professional oral care vs Usual oral care

Population: Residents of nursing homes and other long-term care facilities
CD012416.PUB2 · 9 questions
OutcomeEffectEvidenceStatus / GRADE
Mortality (pneumonia-associated)
24 months
RR 0.41 [0.24, 0.72]
154 per 1000 vs 63 per 1000
2 studies · 507 participantsLow
Downgraded: risk of bias
Mortality (all-cause)
24 months
RR 0.55 [0.27, 1.15]
234 per 1000 vs 129 per 1000
1 study · 141 participantsVery low
Downgraded: risk of bias, imprecision
Incidence or prevalence of fever
24 months
RR 0.49 [0.33, 0.75]1 study · 366 participantsUngraded
Adverse effects of interventions
Measured in one study only, which reported that there were no serious events and 64 non-serious events, the most common of which were oral cavity disturbances (not defined) and dental staining.1 study · 834 participantsUngraded
Change in systemic antibiotic use
None of the studies measured this outcome.0 studiesNo studies
Incidence proportion (cumulative incidence) of NHAP
24 months
RR 0.61 [0.37, 1.01]
187 per 1000 vs 114 per 1000
1 study · 366 participantsLow
Downgraded: risk of bias, imprecision
Change in data on economics and quality of life
24 months
Only one study measured quality of life. MMSE change at 24 months: intervention 1.5 + 4.9 (170 participants) vs control 3.0 + 5.9 (152 participants); P = 0.032. Professional oral care mitigated the age-related MMSE…1 study · 322 participantsUngraded
Oral health indices
24 months
RR 2.81 [1.39, 5.69]1 study · 199 participantsUngraded
Incidence rate of NHAP
18 months
HR 0.65 [0.29, 1.46]
5.1 per 10,000 patient-days vs 3.3 per 10,000 patient-days
1 study · 2513 participantsLow
Downgraded: risk of bias, imprecision

Oral care vs No oral care

Population: Residents of nursing homes and other long-term care facilities
CD012416.PUB2 · 5 questions
OutcomeEffectEvidenceStatus / GRADE
Mortality (all-cause)
No studies0 studiesNo studies
Incidence proportion of NHAP
No studies0 studiesNo studies
Incidence rate of NHAP
No studies0 studiesNo studies
Mortality (pneumonia-associated)
No studies0 studiesNo studies
Adverse effects of interventions
No studies0 studiesNo studies

Oral care measures (e.g. professional oral care, oral rinse or swab, topical decontamination with antiseptics) vs No treatment, placebo, usual care, or another oral care measure

Population: Residents of nursing homes and other long-term care facilities
CD012416 · 8 questions
OutcomeEffectEvidenceStatus / GRADE
Adverse reactions to the interventions
Protocol (planned outcome); no studies yetNRNo studies
Mortality (all-cause)
Protocol (planned outcome); no studies yetNRNo studies
Change in systemic antibiotic use
Protocol (planned outcome); no studies yetNRNo studies
Mortality (pneumonia-associated)
Protocol (planned outcome); no studies yetNRNo studies
Incidence, incidence proportion or prevalence of NHAP of any severity
Protocol (planned outcome); no studies yetNRNo studies
Incidence or prevalence of fever
Protocol (planned outcome); no studies yetNRNo studies
Oral health indices
Protocol (planned outcome); no studies yetNRNo studies
Change in data on economics and quality of life
Protocol (planned outcome); no studies yetNRNo studies